Vanguard Group Inc Protalix Bio Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$1.22 - $1.82 $33,380 - $49,797
27,361 Added 9.04%
330,047 $415,000
Q4 2023

Feb 14, 2024
BUY
$1.34 - $1.85 $28,552 - $39,419
21,308 Added 7.57%
302,686 $538,000
Q3 2023

Nov 14, 2023
BUY
$1.49 - $2.02 $76,051 - $103,102
51,041 Added 22.16%
281,378 $467,000
Q2 2023

Aug 14, 2023
BUY
$2.0 - $3.36 $460,674 - $773,932
230,337 New
230,337 $460,000

Others Institutions Holding PLX

# of Institutions
50
Shares Held
3.58M
Call Options Held
61.1K
Put Options Held
36.2K
View Full List

About Protalix BioTherapeutics, Inc.

PLX Quotes by TradingView
  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $108M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email